Saving millions of lives by using the power of advanced medical nanotechnology. Changing the world of medicine by creating tomorrow’s effective drugs and therapies. This is the vision that drives Glycovax Pharma’s Team, our Montreal biopharmaceutical company. Led by the renowned researcher Dr. René Roy, our scientific team is part of the world's elite in medicinal chemistry. The Team have designed one of the most advanced family of technology platforms in the world of nano-medicine. Our goal is to make the most of this innovation: • Curing several types of cancers and other rare diseases with more effective treatments • Reducing the side effects of therapeutics by using medication with targeting head-groups • Preventing the development of common cancers by creating synthetic vaccines and simplified diagnostic tools • Meeting the new challenges of the pharmaceutical industry by facilitating the production of high quality synthetic drugs Glycovax Pharma was co-founded by Koranex Capital and thus benefits from its network and its specific expertise.